1. Home
  2. SXTC

SXTC

China SXT Pharmaceuticals Inc.

Logo China SXT Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 9:36am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.

Founded: 2005 Country:
China
China
Employees: 78 City: N/A
Market Cap: 559.9K IPO Year: 2019
Target Price: N/A AVG Volume (30 days): 1.2M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -26.96 EPS Growth: N/A
52 Week Low/High: $1.39 - $9.38 Next Earning Date: 08-19-2019
Revenue: $29,919 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: